Targeting the tumor microenvironment of Ewing sarcoma Journal Article


Authors: Morales, E.; Olson, M.; Iglesias, F.; Luetkens, T.; Atanackovic, D.
Article Title: Targeting the tumor microenvironment of Ewing sarcoma
Abstract: Ewing sarcoma is an aggressive tumor type with an age peak in adolescence. Despite the use of dose-intensified chemotherapy as well as radiation and surgery for local control, patients with upfront metastatic disease or relapsed disease have a dismal prognosis, highlighting the need for additional therapeutic options. Different types of immunotherapies have been investigated with only very limited clinical success, which may be due to the presence of immunosuppressive factors in the tumor microenvironment. Here we provide an overview on different factors contributing to Ewing sarcoma immune escape. We demonstrate ways to target these factors in order to make current and future immunotherapies more effective and achieve deeper and more durable responses in patients with Ewing sarcoma. © 2021 Future Medicine Ltd.
Keywords: t cells; monoclonal antibodies; ewing sarcoma; cytokines; immunotherapy; cancer vaccines; microenvironment; chemokines; immunosuppression; tumor microenvironment; tumor immunology; immune escape; car t cells; immune checkpoint inhibition; tcr-transduced t cells
Journal Title: Immunotherapy
Volume: 13
Issue: 17
ISSN: 1750-743X
Publisher: Future Medicine  
Date Published: 2021-12-01
Start Page: 1439
End Page: 1451
Language: English
DOI: 10.2217/imt-2020-0341
PROVIDER: scopus
PUBMED: 34670399
DOI/URL:
Notes: Review -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors